Khaled Ibrahim

A Phase II Study of Lipoplatin (Liposomal Cisplatin)/Vinorelbine Combination in HER-2/neu–Negative Metastatic Breast Cancer

Fadi Farhat, Sally Temraz, Joseph Kattan et al. · Clinical Breast Cancer · 2011 · 46 citations

Liposomal Cisplatin, Breast Oncology, Oncology +8

A Long-Acting Curcumin Nanoparticle/In Situ Hydrogel Composite for the Treatment of Uveal Melanoma

Lingxiao Xie, Weizhou Yue, Khaled Ibrahim et al. · Pharmaceutics · 2021 · 45 citations · Full text

Nanotherapeutics, Biomimetic Materials, Engineering +20

Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations

Deborah Mukherji, Bassem Youssef, Christelle Dagher et al. · World Journal of Urology · 2019 · 20 citations · Full text

High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection

Fahad Al Mohareb, Fahad Al Rabiah, Naeem Chaudhri et al. · Hematology/Oncology and Stem Cell Therapy · 2010 · 15 citations · Full text

457 Preliminary results of a phase II study of lipoplatin (liposomal cisplatin)–vinorelbine combination as first line treatment in HER2/neu negative metastatic breast cancer (MBC)

Fadi Farhat, J. Kattan, Khaled Ibrahim et al. · European Journal of Cancer Supplements · 2010 · 14 citations

Liposomal Cisplatin, Breast Oncology, Oncology +10